journal article·2025-10Open access

In Vivo Efficacy of an Antibiotic Wound Gel in a Sheep Model of Bone Trauma and Biofilm‐Related Infection

Annika L. Gilmore, Helena Vu, Korinna M. Hylen, Jacob Adams, Richard T. Epperson, Brooke Kawaguchi, Caroline Garrett, Nicholas N. Ashton, Eric Cozzone, Charles A. Florek, David A. Armbruster, David L. Rothberg, Dustin L. Williams

Abstract

ABSTRACT Traumatic extremity injuries suffer a high probability of infection and often amputation due to contamination and delays in treatment. Military service members are predisposed to injury while engaged in conflict, yet current military adherence to antibiotic administration protocols following traumatic injury is lacking. Moreover, systemic antibiotic prophylaxis might not effectively eradicate biofilm throughout the wound site. Previously, an antibiotic wound gel was created to address current limitations of prophylactic antibiotic treatment in austere environments, particularly the battlefield, by offering a simple solution to control the release of tobramycin over a one‐week period. We hypothesized that tobramycin eluted from the gel would effectively manage biofilm‐related infection when tested in a large animal model of traumatic long‐bone injury. Sheep were either treated with tobramycin‐loaded gel or gel alone, and the reduction in bioburden was determined by quantifying tissue and inoculation substrates after a one‐week period. Results indicated the wound gel was effective at managing biofilm in this model, with no detectable growth observed in tissues collected from treated animals. Further, the antibiotic‐loaded wound gel significantly reduced the severity of the inflammatory response in the surrounding tissue. Biofilm presence was confirmed in scanning electron and light microscopy images of tissues treated with gel alone. Additionally, reactive bone growth, a characteristic of biofilm infection, was consistently observed in all untreated animals but appeared effectively managed in those treated with the antibiotic wound gel. Localized delivery of a broad‐spectrum antibiotic from a controlled‐release gel can improve adherence to antibiotic administration guidelines and has a greater potential to stabilize biofilm‐contaminated wound sites quickly after injury while also mitigating a severe inflammatory response.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Wound Healing and Treatments · Bone fractures and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics University of Utah Salt Lake City Utah USA

Bone and Biofilm Research Lab University of Utah Salt Lake City Utah USA

Department of Biomedical Engineering University of Utah Salt Lake City Utah USA

Noorda College of Osteopathic Medicine Provo Utah USA

Office of Comparative Medicine University of Utah Salt Lake City Utah USA

DePuy Synthes West Chester Pennsylvania USA

Department of Pathology University of Utah Salt Lake City Utah USA

Department of Physical Medicine and Rehabilitation Uniformed Services University Bethesda Maryland USA

Funding

Congressionally Directed Medical Research Programs

References (54)

Show source-provided references
1. 10.1097/00005373‐198408000‐0000910.1097/00005373‐198408000‐00009 ↗
2. 10.2106/jbjs.21.0112610.2106/jbjs.21.01126 ↗
3. 10.1001/jamasurg.2020.725910.1001/jamasurg.2020.7259 ↗
4. 10.1097/corr.000000000000191110.1097/corr.0000000000001911 ↗
5. 10.1002/jor.2429310.1002/jor.24293 ↗
6. 10.1097/BOT.0b013e31802f78fb10.1097/BOT.0b013e31802f78fb ↗
7. 10.1097/TA.0b013e318163c3f510.1097/TA.0b013e318163c3f5 ↗
8. 10.2147/orr.S38484510.2147/orr.S384845 ↗
9. 10.1038/nrc.2017.9310.1038/nrc.2017.93 ↗
10. 10.1186/1471‐2334‐14‐19010.1186/1471‐2334‐14‐190 ↗
11. 10.1099/00221287‐147‐1‐310.1099/00221287‐147‐1‐3 ↗
12. 10.1038/s41522‐023‐00427‐y10.1038/s41522‐023‐00427‐y ↗
13. 10.1007/s00430‐020‐00691‐110.1007/s00430‐020‐00691‐1 ↗
14. 10.1016/j.diagmicrobio.2015.10.01010.1016/j.diagmicrobio.2015.10.010 ↗
15. 10.1089/sur.2017.24010.1089/sur.2017.240 ↗
16. 10.1093/milmed/usz02710.1093/milmed/usz027 ↗
17. 10.1097/bot.000000000000026210.1097/bot.0000000000000262 ↗
18. 10.1080/1090312090314484110.1080/10903120903144841 ↗
19. 10.1080/17453674.2019.157701410.1080/17453674.2019.1577014 ↗
20. 10.1128/aac.8.1.5810.1128/aac.8.1.58 ↗
21. 10.1097/brs.000000000000323810.1097/brs.0000000000003238 ↗
22. 10.1126/science.284.5418.131810.1126/science.284.5418.1318 ↗
23. 10.1007/s11999‐016‐4700‐z10.1007/s11999‐016‐4700‐z ↗
24. 10.7150/jbji.2971110.7150/jbji.29711 ↗
25. 10.1128/aac.00020‐1910.1128/aac.00020‐19 ↗
26. “Deployed Medicine. TCCC Guidelines ”2021.
27. 10.1016/j.wem.2016.12.00410.1016/j.wem.2016.12.004 ↗
28. 10.1093/milmed/usac41810.1093/milmed/usac418 ↗
29. 10.55460/zrik‐eoe310.55460/zrik‐eoe3 ↗
30. 10.1093/milmed/usx14410.1093/milmed/usx144 ↗
31. 10.1093/milmed/usaa37910.1093/milmed/usaa379 ↗
32. 10.1002/jbm.b.3545510.1002/jbm.b.35455 ↗
33. A.Hylen E.Cozzone C.Florek D.Armbruster andD.Williams “In Vitro and Ex Vivo Antibiofilm Testing of a Controlled Release Antibacterial Wound Orotectant ”(2022) (Abstract no 699).
34. 10.3390/microorganisms1208158810.3390/microorganisms12081588 ↗
35. 10.2196/1210710.2196/12107 ↗
36. 10.1016/j.bonr.2021.10112710.1016/j.bonr.2021.101127 ↗
37. Council NR · 2011
38. 10.1002/jbm.a.3412310.1002/jbm.a.34123 ↗
39. 10.1016/s0167‐7012(00)00241‐410.1016/s0167‐7012(00)00241‐4 ↗
40. 10.1016/B978-0-7020-6864-5.00016-510.1016/B978-0-7020-6864-5.00016-5 ↗
41. 10.1179/his.1994.17.4.34310.1179/his.1994.17.4.343 ↗
42. 10.1002/jbm.b.3450910.1002/jbm.b.34509 ↗
43. 10.1179/his.1997.20.2.11910.1179/his.1997.20.2.119 ↗
44. 10.1016/j.tim.2013.06.00210.1016/j.tim.2013.06.002 ↗
45. 10.1097/ta.000000000000020510.1097/ta.0000000000000205 ↗
46. Outcomes in Necrotizing Soft Tissue Infections Are Worse in Rural Versus Urban Montana: A 10‐Year Single Center Retrospective Review
47. Delay to Orthopedic Consultation for Isolated Limb Injury: Cross‐Sectional Survey in a Level 1 Trauma Centre
48. 10.1016/j.biomaterials.2012.08.00310.1016/j.biomaterials.2012.08.003 ↗
49. 10.1089/wound.2015.065310.1089/wound.2015.0653 ↗
50. 10.1097/bot.000000000000209510.1097/bot.0000000000002095 ↗
51. 10.2214/ajr.09.330010.2214/ajr.09.3300 ↗
52. 10.1111/os.1302010.1111/os.13020 ↗
53. 10.1007/s00284‐011‐9908‐210.1007/s00284‐011‐9908‐2 ↗
54. 10.3390/microorganisms1004075910.3390/microorganisms10040759 ↗